v3.26.3
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 114,360 $ 80,616
Investment securities available-for-sale, net of allowance for credit losses of $0 at September 30, 2026 and December 31, 2025 475,168 476,595
Loans, less allowance for credit losses of $19,742 at September 30, 2026 and $19,959 at December 31, 2025 1,479,755 1,495,834
Premises and equipment, net 23,436 24,398
Right-of-use assets 27,549 28,860
Bank owned life insurance 34,479 33,659
Core deposit intangible 9,402 11,101
Goodwill 24,215 24,215
Accrued interest receivable and other assets 77,932 63,245
Total assets 2,266,296 2,238,523
Deposits:    
Non-interest bearing 859,713 848,986
Interest bearing 1,006,930 960,618
Total deposits 1,866,643 1,809,604
Repurchase agreements 62,191 97,855
Lease liabilities 28,063 29,029
Accrued interest payable and other liabilities 30,903 19,946
Borrowings 16,045 21,013
Total liabilities 2,003,845 1,977,447
Commitments and contingencies (Note 5)
Shareholders’ equity:    
Common stock, no par value; 22,500,000 shares authorized; issued and outstanding – 6,943,507 shares at September 30, 2026 and 6,958,814 at December 31, 2025 73,604 75,668
Retained earnings 220,103 195,899
Accumulated other comprehensive loss, net (31,256) (10,491)
Total shareholders’ equity 262,451 261,076
Total liabilities and shareholders’ equity $ 2,266,296 $ 2,238,523